CNPR Product Knowledge 4 — Questions and Answers
Question 1: A 'contraindication' for a drug means:
- The drug is recommended as a first-line therapy for the condition
- A clinical situation in which the drug should NOT be used because the risks outweigh the benefits (Correct answer)
- The drug requires a higher-than-standard dose for the patient
- The drug can be substituted for a related compound without concern
Correct answer: A clinical situation in which the drug should NOT be used because the risks outweigh the benefits
A contraindication is a specific situation or condition in which a drug must not be used because the risk of harm clearly outweighs any potential benefit.
Question 2: What does 'mechanism of action' (MOA) describe in pharmaceutical product knowledge?
- The regulatory pathway used to gain FDA approval
- How a drug produces its pharmacological effect at the molecular or cellular level (Correct answer)
- The route by which a drug is administered to the patient
- The commercial strategy for launching a new drug
Correct answer: How a drug produces its pharmacological effect at the molecular or cellular level
The mechanism of action explains how a drug interacts with its target (receptor, enzyme, ion channel, etc.) to produce its therapeutic effect.
Question 3: Which route of drug administration typically provides the fastest onset of action?
- Oral (PO)
- Subcutaneous (SC)
- Intravenous (IV) (Correct answer)
- Transdermal (TD)
Correct answer: Intravenous (IV)
Intravenous administration delivers the drug directly into the bloodstream, bypassing absorption and providing the fastest onset of action.
Question 4: What is the role of the FDA's Adverse Event Reporting System (FAERS) in post-market drug surveillance?
- It sets drug prices for Medicare and Medicaid programs
- It collects voluntary reports of adverse drug events to monitor drug safety after approval (Correct answer)
- It approves new drug indications submitted by pharmaceutical companies
- It monitors pharmaceutical sales representatives for compliance violations
Correct answer: It collects voluntary reports of adverse drug events to monitor drug safety after approval
FAERS is a database that supports the FDA's post-marketing safety surveillance by collecting and analyzing voluntary reports of adverse drug events and medication errors.
Question 5: In clinical research, what distinguishes a 'double-blind' study design?
- Neither the participants nor the investigators know who is receiving the treatment or placebo (Correct answer)
- Only the participants are unaware of which treatment they are receiving
- Only the investigators are unaware of which treatment participants are receiving
- Both groups receive the active drug at different doses
Correct answer: Neither the participants nor the investigators know who is receiving the treatment or placebo
In a double-blind study, neither the participants nor the researchers know who is in the treatment or control group, minimizing bias in reporting and assessment.
Question 6: What is a 'generic equivalent' drug required to demonstrate to receive FDA approval?
- Superior efficacy compared to the reference brand-name drug
- Bioequivalence to the reference listed drug (RLD), meaning similar bioavailability (Correct answer)
- Identical chemical synthesis process to the original manufacturer
- A new set of Phase III clinical trials proving safety and efficacy
Correct answer: Bioequivalence to the reference listed drug (RLD), meaning similar bioavailability
Generic drugs must demonstrate bioequivalence to the reference listed drug, meaning they deliver the same amount of active ingredient at the same rate to the site of action.
Question 7: Which federal act requires pharmaceutical manufacturers to provide accurate and balanced information when promoting drugs to healthcare professionals?
- The Harrison Narcotic Act of 1914
- The Federal Food, Drug, and Cosmetic Act (FD&C Act) and related FDA regulations (Correct answer)
- The Omnibus Budget Reconciliation Act (OBRA)
- The Health Insurance Portability and Accountability Act (HIPAA)
Correct answer: The Federal Food, Drug, and Cosmetic Act (FD&C Act) and related FDA regulations
The FD&C Act and FDA regulations require that all drug promotion be truthful, non-misleading, and fairly balanced, presenting both benefits and risks.
CNPR Product Knowledge 4
A 'contraindication' for a drug means: